169 related articles for article (PubMed ID: 22551322)
1. Efficacy and adverse effects of the antiviral compound plerixafor in feline immunodeficiency virus-infected cats.
Hartmann K; Stengel C; Klein D; Egberink H; Balzarini J
J Vet Intern Med; 2012; 26(3):483-90. PubMed ID: 22551322
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of the acyclic nucleoside phosphonates (S)-9-(3-fluoro-2-phosphonylmethoxypropyl)adenine (FPMPA) and 9-(2-phosphonylmethoxyethyl)adenine (PMEA) against feline immunodeficiency virus.
Hartmann K; Kuffer M; Balzarini J; Naesens L; Goldberg M; Erfle V; Goebel FD; De Clercq E; Jindrich J; Holy A; Bischofberger N; Kraft W
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Feb; 17(2):120-8. PubMed ID: 9473012
[TBL] [Abstract][Full Text] [Related]
3. Use of two virustatica (AZT, PMEA) in the treatment of FIV and of FeLV seropositive cats with clinical symptoms.
Hartmann K; Donath A; Beer B; Egberink HF; Horzinek MC; Lutz H; Hoffmann-Fezer G; Thum I; Thefeld S
Vet Immunol Immunopathol; 1992 Dec; 35(1-2):167-75. PubMed ID: 1363008
[TBL] [Abstract][Full Text] [Related]
4. [Comparative investigation of the efficacy of two nucleocapsid analogs in FIV infected cats].
Kuffer M; Balzarini J; Rolinski B; Goebel F; Erfle V; Goldberg M; Hartmann K
Tierarztl Prax Ausg K Kleintiere Heimtiere; 1997 Nov; 25(6):671-7. PubMed ID: 9459835
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of 9-(2-phosphonylmethoxyethyl) adenine therapy for feline immunodeficiency virus using a quantitative polymerase chain reaction.
Philpott MS; Ebner JP; Hoover EA
Vet Immunol Immunopathol; 1992 Dec; 35(1-2):155-66. PubMed ID: 1337395
[TBL] [Abstract][Full Text] [Related]
6. Bicyclams, selective antagonists of the human chemokine receptor CXCR4, potently inhibit feline immunodeficiency virus replication.
Egberink HF; De Clercq E; Van Vliet AL; Balzarini J; Bridger GJ; Henson G; Horzinek MC; Schols D
J Virol; 1999 Aug; 73(8):6346-52. PubMed ID: 10400726
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and adverse effects of (R)-9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine in feline immunodeficiency virus-infected cats.
Justa N; Weber K; Klein D; Mueller RS; Sauter-Louis C; Hartmann K
J Vet Intern Med; 2012; 26(6):1267-73. PubMed ID: 23039914
[TBL] [Abstract][Full Text] [Related]
8. (R)-9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine is a potent inhibitor of feline immunodeficiency virus infection.
Vahlenkamp TW; De Ronde A; Balzarini J; Naesens L; De Clercq E; van Eijk MJ; Horzinek MC; Egberink HF
Antimicrob Agents Chemother; 1995 Mar; 39(3):746-9. PubMed ID: 7793884
[TBL] [Abstract][Full Text] [Related]
9. Ability of CD8+ T cell anti-feline immunodeficiency virus (FIV) activity and FIV proviral DNA load in mononuclear cells in FIV-infected cats.
Hohdatsu T; Nakanishi T; Saito I; Koyama H
J Vet Med Sci; 2005 Jan; 67(1):129-31. PubMed ID: 15699611
[TBL] [Abstract][Full Text] [Related]
10. Is AZT/3TC therapy effective against FIV infection or immunopathogenesis?
Arai M; Earl DD; Yamamoto JK
Vet Immunol Immunopathol; 2002 Mar; 85(3-4):189-204. PubMed ID: 11943320
[TBL] [Abstract][Full Text] [Related]
11. Antiviral therapy reduces viral burden but does not prevent thymic involution in young cats infected with feline immunodeficiency virus.
Hayes KA; Phipps AJ; Francke S; Mathes LE
Antimicrob Agents Chemother; 2000 Sep; 44(9):2399-405. PubMed ID: 10952586
[TBL] [Abstract][Full Text] [Related]
12. Suppression of feline immunodeficiency virus infection in vivo by 9-(2-phosphonomethoxyethyl)adenine.
Egberink H; Borst M; Niphuis H; Balzarini J; Neu H; Schellekens H; De Clercq E; Horzinek M; Koolen M
Proc Natl Acad Sci U S A; 1990 Apr; 87(8):3087-91. PubMed ID: 2158102
[TBL] [Abstract][Full Text] [Related]
13. Antiviral treatment of feline immunodeficiency virus-infected cats with (R)-9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine.
Taffin E; Paepe D; Goris N; Auwerx J; Debille M; Neyts J; Van de Maele I; Daminet S
J Feline Med Surg; 2015 Feb; 17(2):79-86. PubMed ID: 24782459
[TBL] [Abstract][Full Text] [Related]
14. Follow-Up of Viral Parameters in FeLV- or FIV-Naturally Infected Cats Treated Orally with Low Doses of Human Interferon Alpha.
Gomez-Lucia E; Collado VM; Miró G; Martín S; Benítez L; Doménech A
Viruses; 2019 Sep; 11(9):. PubMed ID: 31514435
[TBL] [Abstract][Full Text] [Related]
15. Early therapy of feline leukemia virus infection (FeLV-FAIDS) with 9-(2-phosphonylmethoxyethyl)adenine (PMEA).
Hoover EA; Ebner JP; Zeidner NS; Mullins JI
Antiviral Res; 1991 Jul; 16(1):77-92. PubMed ID: 1663730
[TBL] [Abstract][Full Text] [Related]
16. Immunopathologic Effects of Prednisolone and Cyclosporine A on Feline Immunodeficiency Virus Replication and Persistence.
Miller C; Powers J; Musselman E; Mackie R; Elder J; VandeWoude S
Viruses; 2019 Aug; 11(9):. PubMed ID: 31480322
[TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy of the acyclic nucleoside phosphonate 9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine (PMPDAP) in the treatment of feline immunodeficiency virus-infected cats.
Hartmann AD; Wilhelm N; Balzarini J; Hartmann K
J Feline Med Surg; 2012 Feb; 14(2):107-12. PubMed ID: 22314085
[TBL] [Abstract][Full Text] [Related]
18. Contrasting clinical outcomes in two cohorts of cats naturally infected with feline immunodeficiency virus (FIV).
Bęczkowski PM; Litster A; Lin TL; Mellor DJ; Willett BJ; Hosie MJ
Vet Microbiol; 2015 Mar; 176(1-2):50-60. PubMed ID: 25595267
[TBL] [Abstract][Full Text] [Related]
19. Virulence differences between two field isolates of feline immunodeficiency virus (FIV-APetaluma and FIV-CPGammar) in young adult specific pathogen free cats.
Pedersen NC; Leutenegger CM; Woo J; Higgins J
Vet Immunol Immunopathol; 2001 May; 79(1-2):53-67. PubMed ID: 11356250
[TBL] [Abstract][Full Text] [Related]
20. Association between feline immunodeficiency virus (FIV) plasma viral RNA load, concentration of acute phase proteins and disease severity.
Kann RK; Seddon JM; Kyaw-Tanner MT; Henning J; Meers J
Vet J; 2014 Aug; 201(2):181-3. PubMed ID: 24703323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
